Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CMV-MVA Triplex Vaccine in Haploidentical Stem Cell Transplant
NCT03438344Phase 2Withdrawn
- Sponsor
- City of Hope
- Start
- Dec 2018
- Primary completion
- Dec 2021
- Modality
- Viral Vectors, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Triplex in cytomegalovirus infection (CMV), sponsored by City of Hope. Planned start Dec 2018; status: withdrawn.
02
Drugs
Triplex
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT03438344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03438344.